| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2004 | EP1392325A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 03/03/2004 | EP1392324A1 Chemoprotection using amifostine and related compounds |
| 03/03/2004 | EP1392323A2 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes |
| 03/03/2004 | EP1392322A1 Method of treating dry eye disorders |
| 03/03/2004 | EP1392321A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 03/03/2004 | EP1392320A1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 03/03/2004 | EP1392319A2 Hypotensive lipid (prostaglandin) and timolol compositions and methods of using same |
| 03/03/2004 | EP1392318A1 Composition for treating drug-induced constipation with 15-keto-prostaglandins |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392316A1 Benzo[d]azepine derivatives as 5-ht6 receptor antagonists. |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1392314A1 Novel use of 2-phenyl-substituted imidazotriazinones |
| 03/03/2004 | EP1392313A1 Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 03/03/2004 | EP1392312A1 TRIAZOLO 4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/03/2004 | EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 03/03/2004 | EP1392310A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 03/03/2004 | EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 03/03/2004 | EP1392308A1 Alpha-2-adrenergic agonist/fatty acid compositions |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 03/03/2004 | EP1392305A2 Methods for treating neurodegenerative diseases including alzheimer's |
| 03/03/2004 | EP1392304A1 Use of benzothiophenes to treat and prevent prostate cancer |
| 03/03/2004 | EP1392302A1 5-substituted-2-arylpyridines as crf1 modulators |
| 03/03/2004 | EP1392301A2 Prevention of addiction in pain management |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392299A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 03/03/2004 | EP1392298A2 Fused heterocyclic compounds |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392296A1 Thiazolidinediones alone or in conbination with other therapeutic agents for inhibiting or reducing tumour growth |
| 03/03/2004 | EP1392295A1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
| 03/03/2004 | EP1392294A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/03/2004 | EP1392293A1 Method for treatment of tumors using nordihydroguaiaretic acid derivatives |
| 03/03/2004 | EP1392292A2 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/03/2004 | EP1392291A2 Tripeptidyl peptidase inhibitors |
| 03/03/2004 | EP1392290A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392288A2 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus |
| 03/03/2004 | EP1392287A2 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
| 03/03/2004 | EP1392286A2 Antineoplastic combinations |
| 03/03/2004 | EP1392285A1 Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 03/03/2004 | EP1392284A2 Methods of treating hyperlipidemia |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP1392282A2 Dermatological and cosmetic compositions |
| 03/03/2004 | EP1392281A2 Anti-endoparasitic amidoacetonitrils |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392279A1 Trimethyl lock based tetrapartate prodrugs |
| 03/03/2004 | EP1392278A1 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
| 03/03/2004 | EP1392277A2 Pharmaceutical compositions comprising a hmg-coa reductase inhibitor |
| 03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |
| 03/03/2004 | EP1392273A1 Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg |
| 03/03/2004 | EP1392272A1 Permeation enhancers |
| 03/03/2004 | EP1392271A1 Swallow tablet comprising paracetamol |
| 03/03/2004 | EP1392270A2 Abuse resistant pharmaceutical composition containing capsaicin |
| 03/03/2004 | EP1392269A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma |
| 03/03/2004 | EP1392268A2 Medicament containing a polyamine as an active substance |
| 03/03/2004 | EP1392267A1 Preventive or remedy for diseases caused by cerebrovascular disturbances |
| 03/03/2004 | EP1392266A2 Cancer treatment method and compositions comprising compounds of the ginger family |
| 03/03/2004 | EP1392265A2 Inhibitors of abc drug transporters at the blood-brain barrier |
| 03/03/2004 | EP1392264A1 Delivery of antiemetics through an inhalation route |
| 03/03/2004 | EP1392263A2 Delivery of aerosols containing small particles through an inhalation route |
| 03/03/2004 | EP1392262A1 Delivery of drug esters through an inhalation route |
| 03/03/2004 | EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 03/03/2004 | EP1392260A2 Delivery of benzodiazepines through an inhalation route |
| 03/03/2004 | EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route |
| 03/03/2004 | EP1392258A2 Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route |
| 03/03/2004 | EP1392257A1 Delivery of antihistamines through an inhalation route |
| 03/03/2004 | EP1392256A1 Improved transdermal therapeutic system for the treatment of parkinson's disese |
| 03/03/2004 | EP1392255A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 03/03/2004 | EP1392254A1 Micellar drug delivery systems for hydrophobic drugs |
| 03/03/2004 | EP1392252A2 Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl |
| 03/03/2004 | EP1392250A2 Controlled release dosage forms using acrylic polymer, and process for making the same |
| 03/03/2004 | EP1392249A1 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 03/03/2004 | EP1392247A2 Process for preparing granular compositions |
| 03/03/2004 | EP1392246A1 Compaction process for manufacture of sodium phenytoin dosage form |
| 03/03/2004 | EP1392243A2 Topical composition with a lamellar double-membrane structure, containing a n-acyl-ethanolamine and/or a quaternary ammonium salt and/or an adenosylmethionine |
| 03/03/2004 | EP1392242A1 Method of forming an aerosol for inhalation delivery |
| 03/03/2004 | EP1392241A2 System for osmotic delivery of pharmaceutically active agents |
| 03/03/2004 | EP1392239A2 Use of isoflavonoids in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin |
| 03/03/2004 | EP1392230A1 Methods for treating or preventing diseases of the oral cavity |
| 03/03/2004 | EP1392219A2 Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apotosis and the use thereof |
| 03/03/2004 | EP1392116A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 03/03/2004 | EP1392115A1 Controlled release particles |
| 03/03/2004 | EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF |
| 03/03/2004 | EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators |
| 03/03/2004 | EP1282624B1 Crf receptor antagonists and methods relating thereto |
| 03/03/2004 | EP1210345B1 Oxazole ppar antagonists |
| 03/03/2004 | EP1202717B1 Use of naaladase inhibitors for treating anxiety and memory disorders |
| 03/03/2004 | EP1187617B1 Method for selecting the concentration of an amphipathic antihistamine drug by determining the drug's surface activity rating |
| 03/03/2004 | EP1185253B1 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 03/03/2004 | EP1131331B1 13-membered azalides and their use as antibiotic agents |
| 03/03/2004 | EP1130980B1 Beverage for increasing the body's capacity to break down alcohol |
| 03/03/2004 | EP1125575B1 Perfusate preparation for ophthalmic operation |
| 03/03/2004 | EP1124797B1 N-arylsulfonyl amino acid omega amides |
| 03/03/2004 | EP1121134B1 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
| 03/03/2004 | EP1119252A4 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 03/03/2004 | EP1113787B1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same |
| 03/03/2004 | EP1097140B1 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
| 03/03/2004 | EP1087780B1 Extraction method of a compound from vegetable material |